Technology
Results: 1945-1956 of 26420

Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis

Kinaxis Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ Reports for Supply Chain Planning

IRONSCALES Announces New Email Attack of the Day Intelligence Series, Demos Groundbreaking Email Agents at RSAC 2026

Armis Centrix™ Named “Best Solution” for Cyber Exposure Management as Armis Wins Multiple Global InfoSec Awards at RSAC 2026






